Hypoxia-induced miR-181a-5p up-regulation reduces epirubicin sensitivity in breast cancer cells through inhibiting EPDR1/TRPC1 to activate PI3K/AKT signaling pathway

Breast carcinoma (BC) ranks as a predominant malignancy and constitutes the second principal cause of mortality among women globally. Epirubicin stands as the drug of choice for BC therapeutics. Nevertheless, ...

Source: BMC Cancer - February 2, 2024 Category: Cancer & Oncology Authors: Yunwei Zhang, Yunping Guan, Xinyu Zheng and Chenyang Li Tags: Research Source Type: research